Supernus, Inc., formerly Indivior Pharmaceuticals, Inc., is a diversified biopharmaceutical company focused on developing and commercializing treatments for patients living with central nervous system (CNS) diseases. The Company's commercial platform offers various product portfolios consisting of opioid use disorder, psychiatry, and neurology, and includes five core growth drivers, including SUBLOCADE, Qelbree, GOCOVRI, ONAPGO, and ZURZUVAE. Its portfolio includes approved treatments designed to support individuals navigating opioid use disorder (OUD), attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's disease (PD) for those receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea.
Back to dashboard
Company Information
About this company
Key people
Tony Kingsley
Independent Non-Executive Chairman of the Board
Georges Gemayel
Director
Bethany L. Sensenig
Director
Keith Humphreys
Independent Non-Executive Director
Jack A. Khattar
Chief Executive Officer, Director
Timothy C. Dec
Senior Vice President, Chief Financial Officer
Frank Mottola
Senior Vice President, Chief Technical Operations Officer
Padmanabh P. Bhatt
Senior Vice President - Intellectual Property, Chief Scientific Officer
William Todd Horich
Senior Vice President, Chief Commercial Officer
Bryan Roecklein
Senior Vice President, Chief Business Officer
Jonathan Rubin
Senior Vice President, Chief Medical Officer - Research and Development
Carrolee Barlow
Director
Click to see more
Key facts
- Shares in issue207.72m
- EPICSUPN
- ISINUS45579U1097
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$5.86bn
- Employees827
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.